Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON MARKET MIDDAY: Stocks red as UK consumer confidence erodes

(Alliance News) - Stock prices in London were down at midday on Monday, while in corporate news Videndum shares fell after its trading update disappoi...

GSK receives three positive regulatory updates on cancer products

(Alliance News) - GSK PLC on Monday reported a triple dose of good news with positive regulatory updates on two leading cancer drugs.

EU recommends expanding use of GSK endometrial cancer drug

(Sharecast News) - GSK said the European Union's Committee for Medicinal Products for Human Use has recommended expanding approval of Jemperli in comb...

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

GSK PLC - London-based pharmaceuticals firm - Says Dreamm-7 trial shows sustained overall survival benefit for Blenrep, the brand name of belantamab m...

GSK's Nucala and Blenrep receive regulatory boost in US and China

(Alliance News) - GSK PLC on Monday received a double-dose of good news with its Nucala and Blenrep products receiving positive indications from indus...

LONDON BRIEFING: boohoo gets ISS backing amid Frasers Group spat

(Alliance News) - London's FTSE 100 is called higher, while stocks in Hong Kong perked up amid after a slow start amid fresh hope for the Chinese econ...

GSK says US agrees to look at data for new use of COPD drug

(Sharecast News) - GSK said the US Food and Drug Administration has agreed to look at data from its MATINEE study to support the regulatory review pro...